nach oben

Erschienen in:

01.11.2008 | Alzheimer's Disease and Related Disorders - Original Article

Abnormal short latency afferent inhibition in early Alzheimer’s disease: a transcranial magnetic demonstration

verfasst von: Raffaele Nardone, Jürgen Bergmann, Martin Kronbichler, Alexander Kunz, Stefanie Klein, Francesca Caleri, Frediano Tezzon, Gunther Ladurner, Stefan Golaszewski

Erschienen in: Journal of Neural Transmission | Ausgabe 11/2008

Einloggen, um Zugang zu erhalten

Abstract

The pathogenesis of Alzheimer’s disease (AD) appears to involve several different mechanisms, the most consistent of which is an impairment of cholinergic neurotransmission; however, there is controversy about its relevance at the early stage of disease. A transcranial magnetic stimulation (TMS) protocol based on coupling peripheral nerve stimulation with motor cortex TMS (short latency afferent inhibition, SAI) may give direct information about the function of some cholinergic pathways in the human motor cortex. We evaluated SAI in a group of patients with early diagnosis of AD and compared the data with that from a control group. The amount of SAI was significantly smaller in early AD patients than in controls. This study first provides physiological evidence that a central cholinergic dysfunction occurs in the earlier stages of AD. Identification of SAI abnormalities that occur early in the course of AD will allow earlier diagnosis and treatment with cholinergic drugs.

Almkvist O, Winblad B (1999) Early diagnosis of Alzheimer dementia based on clinical and biological factors. Eur Arch Psychiatry Clin Neurosci 249:3–9PubMedCrossRef

Bartus T (1979) Physostigmine and recent memory: effects in young and aged nonhuman primates. Science 206:1085–1087CrossRef

Bartus RT, Dean RL, Beer B, Lippa AS (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217:408–417PubMedCrossRef

Bartus RT, Emerich DF (1999) Cholinergic markers in Alzheimer disease. J Am Med Assoc 282:2208–2209CrossRef

Bierer LM, Haroutunian V, Gabriel S, Knott PJ, Carlin LS, Purohit DP, Perl DP, Schmeidler J, Kanof P, Davis KG (1995) Neurochemical correlates of dementia severity in Alzheimer’s disease: relative importance of the cholinergic deficits. J Neurochem 64:749–760PubMed

Blokland A (1996) Acetylcholine: a neurotransmitter for learning and memory? Brain Res Rev 21:285–300CrossRef

Bohnen NI, Kaufer DI, Hendrickson R, Constantine GM, Mathis CA, Moore RY (2007) Cortical cholinergic denervation is associated with depressive symptoms in Parkinson’s disease and parkinsonian dementia. J Neurol Neurosurg Psychiatry 78:641–643PubMedCrossRef

Davies P, Maloney AJ (1976) Selective loss of central cholinergic neurons in Alzheimer’s disease. Lancet 2(8000):1403PubMedCrossRef

Davis KL, Mohs RC, Marin D, Purohit DP, Perl DP, Lantz M, Austin G, Haroutunian V (1999) Cholinergic markers in elderly patients with early signs of Alzheimer disease. JAMA 281:1401–1406PubMedCrossRef

DeKosky ST, Ikonomovic MD, Styren SD, Beckett L, Wisniewski S, Bennett DA, Cochran EJ, Kordoner JH, Mufson EJ (2002) Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann Neurol 51:145–155PubMedCrossRef

Di Lazzaro V, Oliviero A, Profice P, Pennini MA, Di Giovanni S, Zito G, Tonali P, Rothwell JC (2000) Muscarinic receptor blockade has differential effects on the excitability of intracortical circuits in the human motor cortex. Exp Brain Res 135:455–461PubMedCrossRef

Di Lazzaro V, Oliviero A, Tonali PA, Marra C, Daniele A, Profice P, Saturno E, Pilato F, Masullo C, Rothwll JC (2002) Noninvasive in vivo assessment of cholinergic cortical circuits in AD using transcranial magnetic stimulation. Neurology 13:392–397

Di Lazzaro V, Oliviero A, Pilato F, Saturno E, Dileone M, Marra C, Daniele A, Ghirlanda S, Gainotti G, Tonali PA (2004) Motor cortex excitability to transcranial magnetic stimulation in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 75:555–559PubMedCrossRef

Di Lazzaro V, Oliviero A, Pilato F, Saturno E, Dileone M, Marra C, Daniele A, Ghirlanda S, Gainotti G, Tonali PA (2005a) Neurophysiological predictors of long term response to AchE inhibitors in AD patients. J Neurol Neurosurg Psychiatry 76:1064–1069PubMedCrossRef

Di Lazzaro V, Oliviero A, Saturno E, Dileone M, Pilato F, Nardone R, Ranieri F, Musumeci G, Fiorilla T, Tonali P (2005b) Effects of lorazepam on short latency afferent inhibition and short latency intracortical inhibition in humans. J Physiol 564:661–668PubMedCrossRef

Di Lazzaro V, Pilato F, Dileone M, Tonali PA, Ziemann U (2005c) Dissociated effects of diazepam and lorazepam on short-latency afferent inhibition. J Physiol 569:315–323PubMedCrossRef

Di Lazzaro V, Pilato F, Dileone M, Saturno E, Oliviero A, Marra C, Daniele A, Ranieri F, Gainotti G, Tonali PA (2006) In vivo cholinergic circuit evaluation in frontotemporal and Alzheimer dementias. Neurology 66:1111–1113PubMedCrossRef

Geula C (1998) Abnormalities of neural circuitry in Alzheimer’s disease: hippocampus and cortical cholinergic innervation. Neurology 51:S18–S29PubMed

Gilmor ML, Erickson JD, Varoqui H, Hersh LB, Bennett DA, Cochran EJ, Mufson EJ, Levey AI (1999) Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer’s disease. J Comp Neurol 411:693–704PubMedCrossRef

Hallett M (2000) Transcranial magnetic stimulation and the human brain. Nature 406:147–150PubMedCrossRef

Herholz K, Bauer B, Wienhard K, Kracht L, Mielke R, Lenz O, Strotmann T, Heiss WD (2000) In-vivo measurements of regional acetylcholine esterase activity in degenerative dementia: comparison with blood flow and glucose metabolism. J Neural Transm 12:1457–1468CrossRef

Herholz K, Weisenbach S, Zundorf G, Lenz O, Schroder H, Bauer B, Kalbe E, Heiss WD (2004) In-vivo study of acetylcholine esterase in basel forebrain, amygdala, and cortex in mild to moderate Alzheimer disease. Neuroimage 21:136–143PubMedCrossRef

Iyo M, Namba H, Fukushi K, Shinotoh H, Nagatsuka S, Suhara T, Sodo Y, Sukuki K, Irie T (1997) Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimers disease. Lancet 349:1805–1809PubMedCrossRef

Kasa P, Rakonczay Z, Gulya K (1997) The cholinergic system in Alzheimer’s disease. Prog Neurobiol 52:511–535PubMedCrossRef

Kuhl DE, Koeppe RA, Fessler JA, Minoshima S, Ackermann RJ, Carey JE, Gildersleeve DL, Frey KA, Wieland DM (1994) In vivo mapping of cholinergic neurons in the human brain using SPECT and IBVM. J Nucl Med 35:405–410PubMed

Kujirai T, Caramia MD, Rothwell JC, Day BL, Thompson PD, Ferbert A, Wroe S, Asselman P, Marsden CD (1993) Cortico-cortical inhibition in human motor cortex. J Physiol 471:501–520PubMed

McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology 34:939–944PubMed

Mesulam M, Shaw P, Mash D, Weintraub S (2004) Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum. Ann Neurol 55(6):815–828PubMedCrossRef

Mufson EJ, Ma SY, Cochran EJ, Bennett DA, Beckett LA, Jaffar S, Saragovi HU, Kordower JH (2000) Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer’s disease. J Comp Neurol 427:9–30CrossRef

Nordberg A, Lundqvist H, Hartvig P, Lilja A, Langstrom B (1995) Kinetic analysis of regional (S)(−)11C-nicotine binding in normal and Alzheimer brains—in vivo assessment using positron emission tomography. Alzheimer Dis Assoc Disord 9:21–27PubMedCrossRef

O’Brien JT, Colloby SJ, Pakrasi S, Perry EK, Pimlott S, Land DJ, Wyper DJ, McKeith IG, Williams ED (2007) Alpha4beta2 nicotinic receptor status in Alzheimer’s disease using 123I–5IA–85380 single-photon-emission computed tomography. J Neurol Neurosurg Psychiatry 78:356–362PubMedCrossRef

Perry EK, Tomlinson BE, Blessed G, Bergmann K, Gibson PH, Perry RH (1978) Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br Med J 2:1457–1459PubMedCrossRef

Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild vognitive impairment: clinical characterization and outcome. Arch Neurol 56:303–308PubMedCrossRef

Reinikainen KJ, Soininen H, Riekkinen PJ (1990) Neurotransmitter changes in Alzheimer’s disease: implications to diagnostics and therapy. J Neurosci Res 27:576–586PubMedCrossRef

Rinne JO, Kaasinen V, Jarvenpaa T, Nagren K, Roivainen A, Yu M, Oikonen V, Kurki T (2003) Brain acetylcholinesterase activity in mild cognitive impairment and early Alzheimer’s disease. J Neurol Neurosurg Psychiatry 74:113–115PubMedCrossRef

Rossini PM, Barker T, Berardelli A, Caramia MD, Caruso G, Cracco RQ, Dimitrijevic MR, Hallett M, Katayama Y, Lucking CH, Maertens de Noordhout AL, Marsden CD, Murray NMF, Rothwell JC, Swash M, Tomberg C (1994) Non invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application: report of IFCN committee. Electroencephalogr clin Neurophysiol 91:79–92PubMedCrossRef

Rothwell JC (2003) Techniques of transcranial magnetic stimulation. In: Boniface SJ, Ziemann U (eds) Plasticity in human nervous system. Investigations with transcranial magnetic stimulation. University Press, Cambridge, pp 26–61

Sakuma K, Murakami T, Nakashima K (2007) Short latency afferent inhibition is not impaired in mild cognitive impairment. Clin Neurophysiol 118(7):1460–1463PubMedCrossRef

Sailer A, Molnar GF, Paradiso G, Gunraj CA, Lang AE, Chen R (2003) Short and long latency afferent inhibition in Parkinson’s disease. Brain 126:1883–1894PubMedCrossRef

Saykin AJ, Wishart HA, Rabin LA, Flashman LA, McHugh TL, Mamourian AC (2004) Cholinergic enhancement of frontal lobe activity in mild cognitive impairment. Brain 127:1574–1583PubMedCrossRef

Shinotoh H, Namba H, Fukushi K, Nagatsuka S, Tanaka N, Aotsuka A, Ota T, Tanada S, Irie T (2000) Progressive loss of cortical acetylcholinesterase activity in association with cognitive decline in Alzheimer’s disease: a positron emission tomography study. Ann Neurol 48:194–200PubMedCrossRef

Shinotoh H, Fukushi K, Nagatsuka S, Tanaka N, Aotsuka A, Ota T (2003) The amygdala and Alzheimer’s disease: positron emission tomographic study of the cholinergic system. Ann N Y Acad Sci 985:411–419PubMedCrossRef

Smith G (1988) Animal models of Alzheimer’s disease: experimental cholinergic denervation. Brain Res Rev 13:103–118CrossRef

Stokin GB, Lillo C, Falzone TL, Brusch RG, Rockenstein E, Mount SL, Roman R, Davies P, Masliah E, Williams DsS Goldstein LS (2005) Axonopathy and transport deficits early in the pathogenesis of Alzheimer’s disease. Science 307:1282–1288PubMedCrossRef

Tokimura H, Di Lazzaro V, Tokimura Y, Oliviero A, Profice P, Insola A, Mazzone P, Tonali P, Rothwell JC (2000) Short latency inhibition of human hand motor cortex by somatosensory input from the hand. J Physiol 523:503–513PubMedCrossRef

Voytko ML, Olton DS, Richardson RT, Gorman LK, Tobin JR, Price DL (1994) Basal forebrain lesions in monkeys disrupt attention but not learning and memory. J Neurosci 14:167–186PubMed

Whitehouse PJ, Price DL, Clark AW, Coyle JT, DeLong MR (1981) Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol 10:122–126PubMedCrossRef

Ziemann U (2002) Assessment of motor cortex and descending motor pathways. In: Brown WF, Bolton CF, Aminoff MJ (eds) Neuromuscular function and disease. Basis, clinical and electrodiagnostic aspects aspects, vol 1. Saunders, Philadelphia, pp 189–221

Ziemann U (2004) TMS and drugs. Clin Neurophysiol 115:1717–1729PubMedCrossRef

Titel: Abnormal short latency afferent inhibition in early Alzheimer’s disease: a transcranial magnetic demonstration
verfasst von: Raffaele Nardone
Jürgen Bergmann
Martin Kronbichler
Alexander Kunz
Stefanie Klein
Francesca Caleri
Frediano Tezzon
Gunther Ladurner
Stefan Golaszewski
Publikationsdatum: 01.11.2008
Verlag: Springer Vienna
Erschienen in: Journal of Neural Transmission / Ausgabe 11/2008
Print ISSN: 0300-9564
Elektronische ISSN: 1435-1463
DOI: https://doi.org/10.1007/s00702-008-0129-1

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2008

Baroreflex sensitivity and power spectral analysis in different extrapyramidal syndromes

Lack of NMDA–AMPA interaction in antidepressant-like effect of CGP 37849, an antagonist of NMDA receptor, in the forced swim test

A longitudinal study of schizophrenia- and affective spectrum disorders in individuals diagnosed with a developmental language disorder as children

SNAP-25 genotype influences NAA/Cho in left hippocampus

Evaluation of interactions between cannabinoid compounds and diazepam in electroshock-induced seizure model in mice